Copyright
©The Author(s) 2015.
World J Hepatol. Jan 27, 2015; 7(1): 7-27
Published online Jan 27, 2015. doi: 10.4254/wjh.v7.i1.7
Published online Jan 27, 2015. doi: 10.4254/wjh.v7.i1.7
Ref. | Clone | Source | Dilution | Antigen retrieval | Cut-off value1 |
Tseng et al[11] | DO-7 | DAKO | 1:100 | Citrate buffer | > 5% nuclear p53 staining |
Hu et al[13] | DO-7 | DAKO | 1:1000 | Citrate buffer | > 10% nuclear p53 staining |
Kang et al[14] | DO-7 | DAKO | 1:100 | Citrate buffer | > 5% nuclear p53 staining |
Stroescu et al[16] | DO-7 | DAKO | Not reported | Citrate buffer | < 24% nuclear p53 staining |
Sung et al[17] | Bp53-12 | Zymed | 1:80 | Citrate buffer | > 5% nuclear p53 staining |
Qin et al[19] | DO-7 | DAKO | Not reported | Citrate buffer | ≥ 10% nuclear p53 staining |
Guo et al[20] | CM1 | SDC | 1:2000 | Citrate buffer | > 5% nuclear p53 staining |
Umemura et al[21] | DO-7 | DAKO | 1:50 | Citrate buffer | ≥ 10% nuclear p53 staining |
- Citation: Niu ZS, Niu XJ, Wang M. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival. World J Hepatol 2015; 7(1): 7-27
- URL: https://www.wjgnet.com/1948-5182/full/v7/i1/7.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i1.7